Picture of US Physical Therapy logo

USPH — US Physical Therapy News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

US Physical Therapy Inc reports results for the quarter ended June 30 - Earnings Summary

US Physical Therapy Inc USPH.N reported quarterly adjusted earnings of 81 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 73 cents.  The mean expectation of seven analysts for the quarter was for earnings of 72 cents per share. Wall Street expected results to range from 63 cents to 78 cents per share.

Revenue rose 18% to $197.34 million from a year ago; analysts expected $189.60 million.

US Physical Therapy Inc's reported EPS for the quarter was 58 cents​.

The company reported quarterly net income of $12.39 million.

US Physical Therapy Inc shares had fallen by 7.9% this quarter and lost 18.8% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 4.2% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

Wall Street's median 12-month price target for US Physical Therapy Inc is $107.00, about 32.1% above its last closing price of $72.69

This summary was machine generated from LSEG data August 6 at 11:14 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Jun. 30 20250.720.81Beat
Mar. 31 20250.430.48Beat
Dec. 31 20240.690.65Missed
Sep. 30 20240.680.69Beat

Recent news on US Physical Therapy

See all news